GB1017674A - Coated pharmaceutical compositions - Google Patents

Coated pharmaceutical compositions

Info

Publication number
GB1017674A
GB1017674A GB36293/64A GB3629364A GB1017674A GB 1017674 A GB1017674 A GB 1017674A GB 36293/64 A GB36293/64 A GB 36293/64A GB 3629364 A GB3629364 A GB 3629364A GB 1017674 A GB1017674 A GB 1017674A
Authority
GB
United Kingdom
Prior art keywords
acid
amino
cellulose
alkali
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB36293/64A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1017674A publication Critical patent/GB1017674A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB36293/64A 1963-09-10 1964-09-04 Coated pharmaceutical compositions Expired GB1017674A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1115563 1963-09-10

Publications (1)

Publication Number Publication Date
GB1017674A true GB1017674A (en) 1966-01-19

Family

ID=4370622

Family Applications (1)

Application Number Title Priority Date Filing Date
GB36293/64A Expired GB1017674A (en) 1963-09-10 1964-09-04 Coated pharmaceutical compositions

Country Status (10)

Country Link
US (1) US3431338A (enExample)
BE (1) BE652807A (enExample)
BR (1) BR6462426D0 (enExample)
DE (1) DE1204363B (enExample)
DK (1) DK112191B (enExample)
ES (1) ES303909A1 (enExample)
FR (1) FR4213M (enExample)
GB (1) GB1017674A (enExample)
IL (1) IL21981A (enExample)
NL (1) NL6410434A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000435A1 (en) * 1981-07-31 1983-02-17 Rhodes, John Orally administrable pharmaceutical compositions
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
EP2753310B1 (de) 2011-09-07 2021-03-24 Roland Saur-Brosch Formulierung zur kontrollierten freisetzung eines oder mehreren stoffe im verdauungstrakt eines säugetiers

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1115596B (it) * 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US4965089A (en) * 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
AU689250B2 (en) 1994-04-22 1998-03-26 Astellas Pharma Inc. Colon-specific drug release system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
AR053805A1 (es) * 2005-05-31 2007-05-23 Iams Company Bifidobacterias probioticas para felinos
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
RU2309731C1 (ru) * 2006-09-29 2007-11-10 Исаак Григорьевич Гитлин Гранулят эметина гидрохлорида, способ его получения и лекарственная форма на его основе
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957804A (en) * 1958-06-06 1960-10-25 Harlan R Shuyler Pesticide

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000435A1 (en) * 1981-07-31 1983-02-17 Rhodes, John Orally administrable pharmaceutical compositions
US5541170A (en) * 1981-07-31 1996-07-30 Tillotts Pharma Ag Orally administrable pharmaceutical compositions
US5541171A (en) * 1981-07-31 1996-07-30 Tillotts Pharma Ag Orally administrable pharmaceutical composition
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
EP2753310B1 (de) 2011-09-07 2021-03-24 Roland Saur-Brosch Formulierung zur kontrollierten freisetzung eines oder mehreren stoffe im verdauungstrakt eines säugetiers

Also Published As

Publication number Publication date
NL6410434A (enExample) 1965-03-11
ES303909A1 (es) 1965-07-16
BE652807A (enExample) 1965-03-08
DK112191B (da) 1968-11-18
US3431338A (en) 1969-03-04
IL21981A (en) 1968-02-26
FR4213M (enExample) 1966-06-13
DE1204363B (de) 1965-11-04
BR6462426D0 (pt) 1973-08-07

Similar Documents

Publication Publication Date Title
GB1017674A (en) Coated pharmaceutical compositions
EP0072021B1 (en) Aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents, a process for preparing the same, and a solid medicinal oral dosage form containing an enteric coating prepared by using same
KR840000230A (ko) 브롬헥신 서방출성 제형의 제조방법
IL42044A (en) 1,4-dihydropyridine carboxylic acid esters,their production and pharmaceutical compositions containing them
DK128283D0 (da) Farmaceutiske praeparater, der kan administreres oralt
CA1014686A (en) Photopolymerizable compositions prepared from beta-hydroxy esters and polyitaconates
AU563725B2 (en) Oral controlled release multiple unit formulation
CA927993A (en) Copolymers of oligoesters having maleic acid end groups and vinyl monomers
IL35098A0 (en) Mono-amides of phthalic and pyridine di-carboxylic acids,their preparation and pharmaceutical compositions containing them
CA1003751A (fr) Compositions pharmaceutiques a base d'antibiotiques et d'acide pyrrolidone-carboxylique ou de ses derives
IL37013A0 (en) Basically substituted alkylidene-aminooxyalkyl carboxylic acid esters,their preparation and pharmaceutical compositions containing them
ES381267A1 (es) Procedimiento para la preparacion de composiciones de re- vestimiento.
IL34255A0 (en) ((thenylidene amino)oxy)alkyl carboxylic acids,their esters and salts,their preparation and pharmaceutical compositions containing them
IL37627A0 (en) 1,2,3,6-tetrahydro-4-pyridylmethyl esters of carboxylic acids and salts thereof,their preparation and pharmaceutical compositions containing them
FR2135021A2 (en) Medicine capsules - dissolving in intestine with wall consisting of two polymers eg hydroxypropylcellulose and cellulose acetophthalat
FR2100561A2 (en) Medicine capsules - dissolving in intestine with wall consisting of two polymers eg hydroxypropylcellulose and cellulose acetophthalat
CA968709A (en) Pharmaceutical compositions involving tricyclic carboxylic acids
JPS5583712A (en) Preparation of pharmaceuticals having enteric coating
CA856347A (en) Copolymers of alkyl esters of alpha, beta-unsaturated mono-carboxylic acids, their preparation, and their use in coating compositions
AU476340B2 (en) Substituted 4-biphenylyl-butenoic acids, esters and amides and pharmaceutical compositions containing them
IL34769A (en) Alpha-(4-isobutyl-1-cyclohexen-1-yl)-alkanoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them
CA854755A (en) Freeze-thaw resistant polyvinyl ester dispersions and process for making them
AU465063B2 (en) Photopolymerizable compositions prepared from beta-hydroxy esters and polyitaconates
AU443569B2 (en) Preparation of soluble poly(vinyl esters from high molecular weight acid chlorides
IL32084A (en) Substituted esters of p-(pyrryl-1)-phenyl acetic acids,their preparation and pharmaceutical compositions containing them